Prostate cancer decisions — 2022

The Veteran's claim for TDIU prior to May 26, 2021 is remanded due to insufficient evidence of unemployability due to service-connected disabilities. The case will be referred to the Director of Compensation Service for extraschedular consideration.

The Board has remanded the case due to inadequate medical opinion regarding the onset and relationship of the Veteran's prostate cancer to service. The claim will be further developed with a new VA examination.

The Veteran's prostate cancer is granted as secondary to herbicide exposure from C-123 aircrafts at Hanscom Air Force Base.

The Veteran's service connection claims for diabetes mellitus type II and prostate cancer are granted based on presumed exposure to herbicide agents during his service in Thailand.

The Veteran's ischemic heart disease, prostate cancer, and hypertension are granted as service connected due to herbicide exposure in Thailand. The issue of entitlement to service connection for hypertension on a direct basis is remanded.

The Veteran's claims for service connection for coronary artery disease and prostate cancer are granted due to the PACT Act, which expanded the presumption of exposure to herbicide agents. The diseases are presumed related to in-service exposure.

The Veteran's service connection claim for prostate cancer is granted due to presumed exposure to herbicide agents (Agent Orange) during his service in Thailand. The Board found the evidence sufficient to establish that the Veteran was exposed to Agent Orange and thus, service connection is granted.

The Veteran is granted a 10 percent disability rating for bowel incontinence, associated with residuals of prostate cancer, effective May 11, 2016. The appeal was denied for ratings higher than the assigned 10 percent rating.

The Veteran's initial 100% disability rating for prostate cancer prior to August 28, 2008 is granted. The earlier effective date of March 1, 2009 for a 20% disability rating for residuals of a prostatectomy is also granted. However, the Veteran's request for a higher disability rating from March 1, 2009 is denied.

The Veteran's service-connected disabilities (coronary artery disease, prostate cancer, erectile dysfunction, and right femoral epicondyle fracture residuals) rendered him unable to secure and follow a substantially gainful occupation prior to November 12, 2019. As a result, the Board granted TDIU for this period.

The Veteran's prostate and bladder cancers are presumed due to military environmental exposure, specifically Agent Orange. Service connection is granted for these conditions.,The Veteran's colon cancer and metastatic stomach cancer are also presumed due to military environmental exposure, specifically Agent Orange. Service connection is remanded for further review.

The Veteran's prostate cancer was granted service connection effective October 27, 2020.,Service connection for lumbosacral strain degenerative disc disease, intervertebral disc syndrome, and degenerative arthritis with spinal stenosis was granted effective December 30, 2016. The Veteran's radiculopathy of the right lower extremity (sciatic nerve) and left lower extremity (sciatic nerve), as well as his radiculopathy of the right lower extremity (femoral nerve) and left lower extremity (femoral nerve), were all granted service connection effective December 30, 2016.,The Veteran's prostate cancer is rated at 100% since October 27, 2020.

The Veteran's death prevented the appellant from filing a new claim for an earlier effective date based on clear and unmistakable error (CUE) in a prior rating decision. The appeal is denied.

The Veteran's claims for service connection for prostate cancer and hypertension, both claimed as due to herbicide exposure, have been denied. The evidence submitted does not support the presumption of herbicide exposure or establish a direct link between the conditions and military service.

The Veteran's prostate cancer and lung cancer are being remanded for further development as the Board found that there is insufficient evidence to establish a causal relationship between these conditions and his service, including exposure to contaminants at Camp Lejeune.

The Board denied the Veteran's claims for service connection for ischemic heart disease and prostate cancer, finding that there was no evidence of herbicide exposure or in-service injury/disease leading to these conditions.

The Board has remanded the case due to new legislation (PACT Act) requiring further research into the Veteran's exposure to herbicide agents, specifically if he visited Guam or other specified territories during his service.

The Board has reopened the Veteran's previously denied claim of service connection for prostate cancer and granted it, finding that new evidence supports a presumption of exposure to herbicides during service. The Veteran is now entitled to presumptive service connection for his prostate cancer.

The Board has decided to remand the case due to the need for further medical examination and opinion regarding the Veteran's claims of service connection for oral cancer, prostate cancer, and their relationship.

The Board denied service connection for prostate cancer, finding no evidence linking the condition to in-service exposure to radiation and rejecting the Veteran's claim based on lack of probative evidence.